These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 7285029

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F, Gronda E, Bossi M, Rovelli F.
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract] [Full Text] [Related]

  • 4. Vasodilator therapy in congestive heart failure.
    Mason DT.
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):36-42. PubMed ID: 7344600
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vasodilator therapy--a physiologic approach to the treatment of heart failure.
    Braunwald E.
    N Engl J Med; 1977 Aug 11; 297(6):331-3. PubMed ID: 876316
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oral vasodilator therapy with prazosin in severe congestive heart failure.
    Awan NA, Mason DT.
    Am Heart J; 1981 May 11; 101(5):695-700. PubMed ID: 7223616
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Sustained and beneficial hemodynamic effects of prazosin in cardiac insufficiency].
    Harrison DC, Feldman RC, Ball RM.
    Cardiology; 1980 May 11; 66 Suppl 2():162-8. PubMed ID: 6456814
    [No Abstract] [Full Text] [Related]

  • 14. [Long-term treatment of cardiac insufficiency with prazosin].
    Grolleau R, Errera J, Gallay P.
    Ann Cardiol Angeiol (Paris); 1984 May 11; 33(4):247-51. PubMed ID: 6465817
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA, Needham KE, Evenson MK, Amsterdam EE, Mason DT.
    Am J Med; 1981 Jul 11; 71(1):153-60. PubMed ID: 7246573
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Chatterjee K, Rubin SA, Ports TA, Parmley WW.
    Am J Med; 1981 Jul 11; 71(1):140-6. PubMed ID: 7246571
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.